Model
Edge
CNS Pharmaceuticals Inc.
CNSP
Filing Type
8-K
Filing Date
11/20/2025
Updated
11/21/25, 3:19 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Shareholder votes
EX-3.1
CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION
EX-10.1
2020 EQUITY PLAN (AS AMENDED AND RESTATED)
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic